<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30069687</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>12</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>23</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1432-0851</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>67</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer immunology, immunotherapy : CII</Title>                <ISOAbbreviation>Cancer Immunol. Immunother.</ISOAbbreviation>            </Journal>            <ArticleTitle>Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.</ArticleTitle>            <Pagination>                <MedlinePgn>1603-1609</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00262-018-2217-x</ELocationID>            <Abstract>                <AbstractText>A 62-year-old woman who underwent surgery to treat pancreatic cancer provided written, informed consent to undergo adjuvant therapy with gemcitabine, tegafur, and uracil. However, this was stopped after only 14 days due to Grade 4 neutropenia. She was then started on vaccine therapy with Survivin 2B peptide (SVN-2B) including IFA and INF-α. Although metastatic lung tumors were identified and resected at 82 months after surgery, the patient has remained free of new or relapsed disease for 12 years thereafter. Tetramer and ELISPOT assays revealed the continuous circulation of SVN-2B-restricted cytotoxic T-lymphocytes (CTLs) in her peripheral blood, and CTL clones had specific activity for SVN-2B at 12 years after surgery. The adverse effects of the peptide vaccination were tolerable and comprised low-grade headache, nausea, and fatigue. A prognosis beyond 10 years in the face of pancreatic cancer with distant metastasis is extremely rare. This experience might indicate the value of cancer vaccination therapy.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Shima</LastName>                    <ForeName>Hiroaki</ForeName>                    <Initials>H</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4413-2008</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan. simahiro@sapmed.ac.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kutomi</LastName>                    <ForeName>Goro</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Satomi</LastName>                    <ForeName>Fukino</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Imamura</LastName>                    <ForeName>Masafumi</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kimura</LastName>                    <ForeName>Yasutoshi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mizuguchi</LastName>                    <ForeName>Toru</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Watanabe</LastName>                    <ForeName>Kazue</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medical and Biological Laboratories CO., LTD., Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Takahashi</LastName>                    <ForeName>Akari</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Murai</LastName>                    <ForeName>Aiko</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsukahara</LastName>                    <ForeName>Tomohide</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kanaseki</LastName>                    <ForeName>Takayuki</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hirohashi</LastName>                    <ForeName>Yoshihiko</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Iwayama</LastName>                    <ForeName>Yuji</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Takikawa Municipal Hospital, Takikawa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsuruma</LastName>                    <ForeName>Tetsuhiro</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, JR Sapporo Hospital, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kameshima</LastName>                    <ForeName>Hidekazu</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Odori Breast Thyroid Gland Clinic, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sato</LastName>                    <ForeName>Noriyuki</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Sapporo Dohto Hospital, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Torigoe</LastName>                    <ForeName>Toshihiko</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Sapporo Medical University, Sapporo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Takemasa</LastName>                    <ForeName>Ichiro</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>16209013, 17016061, and 21249025</GrantID>                    <Agency>Scientific Research for the Ministry of Education, Culture, Sports, Science and Technology of Japan</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>15-17 and 19-14</GrantID>                    <Agency>Practical Application Research from the Japan Science and Technology Agency and for Cancer Research from the Ministry of Healthy, Labor and Welfare of Japan</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>17H01540</GrantID>                    <Agency>Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D002363">Case Reports</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>01</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Germany</Country>            <MedlineTA>Cancer Immunol Immunother</MedlineTA>            <NlmUniqueID>8605732</NlmUniqueID>            <ISSNLinking>0340-7004</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C107489">BIRC5 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D019496">Cancer Vaccines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D051034">Inhibitor of Apoptosis Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D022223">Vaccines, Subunit</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Pancreatology. 2016 Jul-Aug;16(4):593-8</RefSource>                <PMID Version="1">27067420</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Res. 2017 May;5(5):417-424</RefSource>                <PMID Version="1">28411193</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Immunother. 2009 Jun;32(5):474-85</RefSource>                <PMID Version="1">19609239</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Hematol. 2008 Oct;88(3):311-320</RefSource>                <PMID Version="1">18677654</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2002 Jun;8(6):1731-9</RefSource>                <PMID Version="1">12060610</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2004 Sep;10(9):909-15</RefSource>                <PMID Version="1">15340416</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Dev Immunol. 2013;2013:262967</RefSource>                <PMID Version="1">24363758</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Immunol. 2013 Oct;14(10):996-1006</RefSource>                <PMID Version="1">24048121</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2005 Apr 12;5:37</RefSource>                <PMID Version="1">15826316</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2011 Jun;102(6):1181-7</RefSource>                <PMID Version="1">21371173</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2015 Dec;106(12):1659-68</RefSource>                <PMID Version="1">26395101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Immunother Cancer. 2016 Sep 20;4:56</RefSource>                <PMID Version="1">27660710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Nov 20;30(33):4077-83</RefSource>                <PMID Version="1">23008325</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2009 May 26;9:160</RefSource>                <PMID Version="1">19470159</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncoimmunology. 2015 Jan 9;4(4):e974411</RefSource>                <PMID Version="1">26137405</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1986 Sep;46(9):4384-9</RefSource>                <PMID Version="1">3488124</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Transl Med. 2004 Jun 13;2(1):19</RefSource>                <PMID Version="1">15193151</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cytometry. 1999 Nov 1;37(3):197-204</RefSource>                <PMID Version="1">10520200</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2013 Jan;104(1):124-9</RefSource>                <PMID Version="1">23078230</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D019496" MajorTopicYN="N">Cancer Vaccines</DescriptorName>                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051034" MajorTopicYN="N">Inhibitor of Apoptosis Proteins</DescriptorName>                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName>                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013602" MajorTopicYN="N">T-Lymphocytes, Cytotoxic</DescriptorName>                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D022223" MajorTopicYN="N">Vaccines, Subunit</DescriptorName>                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Antigen</Keyword>            <Keyword MajorTopicYN="N">Cancer survivor</Keyword>            <Keyword MajorTopicYN="N">Immunology</Keyword>            <Keyword MajorTopicYN="N">Pancreatic neoplasm</Keyword>            <Keyword MajorTopicYN="N">Vaccination</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>12</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30069687</ArticleId>            <ArticleId IdType="doi">10.1007/s00262-018-2217-x</ArticleId>            <ArticleId IdType="pii">10.1007/s00262-018-2217-x</ArticleId>            <ArticleId IdType="pmc">PMC6182403</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>